{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:56:52Z","timestamp":1791874612529,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1038\/nm1353","type":"journal-article","created":{"date-parts":[[2006,2,6]],"date-time":"2006-02-06T09:57:30Z","timestamp":1139219850000},"page":"190-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":283,"title":["A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees"],"prefix":"10.1038","volume":"12","author":[{"given":"Antonella","family":"Folgori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionello","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Meola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Sporeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Bruni","family":"Ercole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Pezzanera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Tafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Arcuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Lahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Luzzago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Vitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Colloca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,2,5]]},"reference":[{"key":"BFnm1353_CR1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/jhep.2002.36806","volume":"36","author":"LB Seeff","year":"2002","unstructured":"Seeff, L.B. Natural history of chronic hepatitis C. Hepatology 36, S35\u2013S46 (2002).","journal-title":"Hepatology"},{"key":"BFnm1353_CR2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","volume":"362","author":"T Poynard","year":"2003","unstructured":"Poynard, T., Yuen, M.F., Ratziu, V. & Lai, C.L. Viral hepatitis C. Lancet 362, 2095\u20132100 (2003).","journal-title":"Lancet"},{"key":"BFnm1353_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nature04081","volume":"436","author":"M Houghton","year":"2005","unstructured":"Houghton M. & Abrignani S,. Prospects for a vaccine against the hepatitis C virus. Nature 436, 961\u2013966 (2005).","journal-title":"Nature"},{"key":"BFnm1353_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","volume":"91","author":"QL Choo","year":"1994","unstructured":"Choo, Q.L. et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 91, 1294\u20131298 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1353_CR5","doi-asserted-by":"publisher","first-page":"15394","DOI":"10.1073\/pnas.93.26.15394","volume":"93","author":"P Farci","year":"1996","unstructured":"Farci, P. et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc. Natl. Acad. Sci. USA 93, 15394\u201315399 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1353_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1126\/science.1279801","volume":"258","author":"P Farci","year":"1992","unstructured":"Farci, P. et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 258, 135\u2013140 (1992).","journal-title":"Science"},{"key":"BFnm1353_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0140-6736(94)91224-6","volume":"343","author":"ME Lai","year":"1994","unstructured":"Lai, M.E. et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 343, 388\u2013390 (1994).","journal-title":"Lancet"},{"key":"BFnm1353_CR8","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1086\/383279","volume":"189","author":"JJ Post","year":"2004","unstructured":"Post, J.J. et al. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort. J. Infect. Dis. 189, 1846\u20131855 (2004).","journal-title":"J. Infect. Dis."},{"key":"BFnm1353_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","volume":"4","author":"S Cooper","year":"1999","unstructured":"Cooper, S. et al. Analysis of a successful immune response against hepatitis C virus. Immunity 4, 439\u2013449 (1999).","journal-title":"Immunity"},{"key":"BFnm1353_CR10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/nature04079","volume":"436","author":"DG Bowen","year":"2005","unstructured":"Bowen, D.G. & Walker, C.M. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436, 946\u2013952 (2005).","journal-title":"Nature"},{"key":"BFnm1353_CR11","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1084\/jem.20030239","volume":"197","author":"NH Shoukry","year":"2003","unstructured":"Shoukry, N.H. et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197, 1645\u20131655 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnm1353_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1126\/science.1088774","volume":"302","author":"A Grakoui","year":"2003","unstructured":"Grakoui, A. et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 302, 659\u2013662 (2003).","journal-title":"Science"},{"key":"BFnm1353_CR13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","volume":"191","author":"F Lechner","year":"2000","unstructured":"Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499\u20131512 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnm1353_CR14","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/gut.2003.037788","volume":"53","author":"E Spada","year":"2004","unstructured":"Spada, E. et al. Multi-specific T-cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 53, 1673\u20131681 (2004).","journal-title":"Gut"},{"key":"BFnm1353_CR15","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"R Thimme","year":"2001","unstructured":"Thimme, R. et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194, 1395\u20131406 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnm1353_CR16","doi-asserted-by":"publisher","first-page":"15661","DOI":"10.1073\/pnas.202608299","volume":"99","author":"R Thimme","year":"2002","unstructured":"Thimme, R. et al. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. USA 99, 15661\u201315668 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1353_CR17","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4049\/jimmunol.169.6.3447","volume":"169","author":"H Wedemeyer","year":"2002","unstructured":"Wedemeyer, H. et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169, 3447\u20133458 (2002).","journal-title":"J. Immunol."},{"key":"BFnm1353_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1172\/JCI118842","volume":"98","author":"G Missale","year":"1996","unstructured":"Missale, G. et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 98, 706\u2013714 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnm1353_CR19","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0140-6736(95)91691-1","volume":"346","author":"HM Diepolder","year":"1995","unstructured":"Diepolder, H.M. et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006\u20131007 (1995).","journal-title":"Lancet"},{"key":"BFnm1353_CR20","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0016-5085(99)70353-7","volume":"117","author":"JT Gerlach","year":"1999","unstructured":"Gerlach, J.T. et al. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C. Gastroenterology 117, 933\u2013941 (1999).","journal-title":"Gastroenterology"},{"key":"BFnm1353_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hep.20749","volume":"42","author":"AS Cox","year":"2005","unstructured":"Cox, A.S. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42, 104\u2013112 (2005).","journal-title":"Hepatology"},{"key":"BFnm1353_CR22","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1002\/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B","volume":"30","author":"F Lechner","year":"2000","unstructured":"Lechner, F. et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30, 2479\u20132487 (2000).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1353_CR23","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/75063","volume":"6","author":"A Takaki","year":"2000","unstructured":"Takaki, A. et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6, 578\u2013582 (2000).","journal-title":"Nat. Med."},{"key":"BFnm1353_CR24","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1053\/jhep.2001.24371","volume":"33","author":"S Bassett","year":"2001","unstructured":"Bassett, S. et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33, 1479\u20131487 (2001).","journal-title":"Hepatology"},{"key":"BFnm1353_CR25","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1128\/JVI.78.3.1575-1581.2004","volume":"78","author":"RE Lanford","year":"2004","unstructured":"Lanford, R.E. et al. Cross-genotype immunity to hepatitis C virus. J. Virol. 78, 1575\u20131581 (2004).","journal-title":"J. Virol."},{"key":"BFnm1353_CR26","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","volume":"359","author":"SH Mehta","year":"2002","unstructured":"Mehta, S.H. et al. Protection against persistence of hepatitis C. Lancet 359, 1478\u20131483 (2002).","journal-title":"Lancet"},{"key":"BFnm1353_CR27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/jvi.65.3.1105-1113.1991","volume":"65","author":"AC Takamizawa","year":"1991","unstructured":"Takamizawa, A.C. et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65, 1105\u20131113 (1991).","journal-title":"J. Virol."},{"key":"BFnm1353_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/104303404322886147","volume":"15","author":"M Aste-Amezaga","year":"2004","unstructured":"Aste-Amezaga, M. et al. Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Hum. Gene Ther. 15, 293\u2013304 (2004).","journal-title":"Hum. Gene Ther."},{"key":"BFnm1353_CR29","unstructured":"Capone, S. et al. A novel Ad6 based HCV vector that overcomes pre-existing anti-Ad5 immunity and induces potent and broad cellular immune responses in Rhesus Macaques. J Virol. (in the press)."},{"key":"BFnm1353_CR30","doi-asserted-by":"publisher","first-page":"10038","DOI":"10.1128\/JVI.76.19.10038-10043.2002","volume":"76","author":"MJ Caulfield","year":"2002","unstructured":"Caulfield, M.J. et al. Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines. J. Virol. 76, 10038\u201310043 (2002).","journal-title":"J. Virol."},{"key":"BFnm1353_CR31","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1053\/jhep.2000.9877","volume":"32","author":"X Forns","year":"2000","unstructured":"Forns, X. et al. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology 32, 618\u2013625 (2000).","journal-title":"Hepatology"},{"key":"BFnm1353_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1128\/JVI.78.1.187-196.2004","volume":"78","author":"C Rollier","year":"2004","unstructured":"Rollier, C. et al. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response. J. Virol. 78, 187\u2013196 (2004).","journal-title":"J. Virol."},{"key":"BFnm1353_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.vaccine.2003.09.010","volume":"22","author":"M Puig","year":"2004","unstructured":"Puig, M., Major, M.E., Mihalik, K. & Feinstone, S.M. Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection. Vaccine 22, 991\u20131000 (2004).","journal-title":"Vaccine"},{"key":"BFnm1353_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/bioinformatics\/bth485","volume":"21","author":"C Kuiken","year":"2005","unstructured":"Kuiken, C., Yusim, K., Boykin, L. & Richardson, R . The Los Alamos hepatitis C sequence database. Bioinformatics 21, 379\u2013384 (2005).","journal-title":"Bioinformatics"},{"key":"BFnm1353_CR35","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1016\/j.ymthe.2004.07.013","volume":"10","author":"N Tatsis","year":"2004","unstructured":"Tatsis, N. & Ertl, H.C. Adenoviruses as vaccine vectors. Mol. Ther. 10, 4616\u20134629 (2004).","journal-title":"Mol. Ther."},{"key":"BFnm1353_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.55.091902.104344","volume":"55","author":"JW Shiver","year":"2004","unstructured":"Shiver, J.W. & Emini, E.A. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 55, 355\u2013372 (2004).","journal-title":"Annu. Rev. Med."},{"key":"BFnm1353_CR37","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jgm.774","volume":"7","author":"I Zampaglione","year":"2005","unstructured":"Zampaglione, I. et al. In vivo DNA gene electro-transfer: a systematic analysis of different electrical parameters. J. Gene Med. 7, 1475\u20131481 (2005).","journal-title":"J. Gene Med."},{"key":"BFnm1353_CR38","doi-asserted-by":"publisher","first-page":"11598","DOI":"10.1128\/JVI.74.24.11598-11607.2000","volume":"74","author":"S Zucchelli","year":"2000","unstructured":"Zucchelli, S. et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J. Virol. 74, 11598\u201311607 (2000).","journal-title":"J. Virol."},{"key":"BFnm1353_CR39","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/hep.20239","volume":"39","author":"ME Major","year":"2004","unstructured":"Major, M.E. et al. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees. Hepatology 39, 1709\u20131720 (2004).","journal-title":"Hepatology"},{"key":"BFnm1353_CR40","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1128\/JVI.72.4.2589-2599.1998","volume":"72","author":"S Bassett","year":"1998","unstructured":"Bassett, S., Brasky, K.M. & Lanford, R.E. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J. Virol. 72, 2589\u20132599 (1998).","journal-title":"J. Virol."},{"key":"BFnm1353_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0168-8278(99)80381-X","volume":"31","author":"MJ Alter","year":"1999","unstructured":"Alter, M.J. Hepatitis C virus infection in the United States. J. Hepatol. 31, 88\u201391 (1999).","journal-title":"J. Hepatol."},{"key":"BFnm1353_CR42","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1097\/00042737-199911000-00005","volume":"11","author":"KD Palitzsch","year":"1999","unstructured":"Palitzsch, K.D. et al. Prevalence of antibodies against hepatitis C virus in the adult German population. Eur. J. Gastroenterol. Hepatol. 11, 1215\u20131220 (1999).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnm1353_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00042737-200105000-00003","volume":"13","author":"S Riestra","year":"2001","unstructured":"Riestra, S. et al. Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur. J. Gastroenterol. Hepatol. 13, 477\u2013481 (2001).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnm1353_CR44","doi-asserted-by":"publisher","first-page":"11434","DOI":"10.1128\/JVI.78.20.11434-11438.2004","volume":"78","author":"DR Casimiro","year":"2004","unstructured":"Casimiro, D.R. et al. Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors. J. Virol. 78, 11434\u201311438 (2004).","journal-title":"J. Virol."},{"key":"BFnm1353_CR45","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1002\/eji.200526067","volume":"35","author":"S Guglietta","year":"2005","unstructured":"Guglietta, S. et al. Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection. Eur J. Immunology 35, 2627\u20132637 (2005).","journal-title":"Eur J. Immunology"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm1353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1353","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1353.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T11:31:47Z","timestamp":1736249507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["BFnm1353"],"URL":"https:\/\/doi.org\/10.1038\/nm1353","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1030969.364432","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,1]]},"assertion":[{"value":"26 July 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}